.png)
The science of addiction has shifted substantially over the past two decades. What was once framed as a failure of willpower or a short-term crisis to be resolved and moved past is now understood as a chronic, relapsing brain disorder, one that requires the same sustained clinical attention given to diabetes, hypertension, or heart disease. The American Society of Addiction Medicine now formally defines addiction as a chronic brain disease influenced by both genetic vulnerability and repeated exposure to substances, and recent advances in neuroimaging and genomic analysis continue to deepen that understanding. Most clinicians working in behavioral health today are familiar with this framework. The harder question is what it actually demands in practice, and whether the monitoring systems supporting patients in recovery have evolved at the same pace as the underlying science.
For many programs, the honest answer is that they haven't.
Adopting the chronic disease model in addiction treatment means more than updating the language in intake paperwork. It means reconceiving the entire arc of care, including what happens long after a patient leaves a structured treatment setting. Chronic disease management is defined by continuity: regular check-ins, real-time data, early intervention at the first sign of deterioration, and a care relationship that does not simply end at discharge.
Addiction care, by contrast, has historically been structured around acute episodes. A patient enters treatment, completes a program, and is discharged with a referral list and perhaps a scheduled follow-up call. The assumption, baked into how many systems are designed and funded, is that the work of treatment is largely done at that point. Research has long identified this mismatch between best practices and current standards of care, noting that the field continues to operate on an acute illness model even as the science points clearly toward something longer and more continuous. Dr. Lori Bohn, a Board-Certified Psychiatric-Mental Health Nurse Practitioner and Medical Director at Voyager Recovery Center, describes the problem plainly:
"Most systems continue to be designed based upon short term episodes of care where after discharge there is little if any structured follow-up planned. As such, many times I have seen people who were very motivated to achieve success, however they did not have the type of continuous support and monitoring provided to those living with chronic illness."
The consequences of that gap are not abstract. Motivation, even genuine and hard-won motivation, does not protect against relapse when the structural scaffolding of support is absent. Patients who thrived in a contained treatment environment can struggle significantly once that environment dissolves, not because they stopped caring, but because the system stopped watching.
Reorienting around chronic disease management means building something more durable than a discharge plan. It means establishing ongoing clinical relationships, predictable touchpoints, and systems capable of detecting early warning signs before a lapse becomes a crisis. As Dr. Bohn puts it:
"I look at this as the beginning of a much longer management process, one that will require consistent actions over time and an ability to adjust accordingly. At work for me, that means focusing on building relationships, establishing routines of ongoing follow up, and developing plans for early intervention."
That framing, treatment as a beginning rather than a conclusion, has real implications for how monitoring is structured. Weekly check-ins and self-reported progress have their place, but they are insufficient as a primary accountability mechanism in a chronic care model. The data arrives too slowly, and self-reporting is vulnerable to the very pressures that characterize early and mid-recovery. Joseph Nightingale, who holds an MBBS and MSc from the University of York and works with Earthbound on evidence-based approaches to health, draws the comparison directly:
"In diabetes or hypertension, clinicians do not wait for obvious deterioration before acting, and substance use care should follow the same logic."
The parallel is worth sitting with. A cardiologist managing a high-risk patient does not rely solely on that patient's verbal account of how they've been feeling. Objective, timely data is built into the protocol. A 2025 integrative review published in Alcohol and Alcoholism found that better clinical outcomes in remote monitoring programs were consistently linked to higher compliance, with patients who missed fewer monitoring samples showing meaningfully stronger results. Recovery monitoring, to meet the same standard, needs infrastructure built around that same logic.
This is where tools like Soberlink have become clinically relevant. Soberlink is an alcohol monitoring system that uses facial recognition and remote breath testing to deliver real-time results to clinicians, family members, and support networks. What makes it meaningfully different from older monitoring approaches is not simply that it tests more frequently, it's that it closes the lag between behavior and response. A result is documented when it happens, not reconstructed days later in a therapy session.
Dr. Bohn describes the clinical value of that immediacy:
"Checking in weekly or relying upon patients' self-reporting is insufficient. We need to establish systems that can identify risk in real time and enable patients and their support networks to take action. Accountability in real time provides a framework by which individuals may feel supported yet accountable, which is a strong synergy in supporting recovery."
Nightingale approaches the same idea from a different angle, focusing on what real-time evidence actually changes clinically:
“I view Soberlink as clinically relevant because it shifts monitoring from retrospective discussion to contemporaneous evidence. Real-time accountability matters because relapse often begins with small lapses in routine, honesty, or follow-up, long before a person asks for help.”
That shift from self-reported to documented, from retrospective to immediate, changes what's clinically possible. Real-time monitoring catches those early signals precisely because it doesn't depend on the patient surfacing them voluntarily. This matters not as a punitive mechanism, but as a clinical one. Catching a pattern early, when intervention is still relatively straightforward, is categorically different from responding to a full relapse. An expert panel published in PMC reinforced this point, noting that monitoring serves both as a check on treatment plan effectiveness and as a meaningful accountability structure, and that many clinicians consider it unwise to set a formal end date for monitoring at all.
There is also a trust dimension that clinicians sometimes underestimate. Dr. Bohn notes that real-time reporting, secure identification, and tamper detection create "a reliability that is similar to what is expected when managing other chronic conditions. This level of accountability empowers patients and creates trust in the data among both families and clinicians." For patients who want to demonstrate their sobriety to skeptical family members or professional licensing boards, objective data is not a burden. It is a resource.
None of this is to suggest that technology alone constitutes a monitoring strategy. Soberlink or any similar tool works as part of a broader system, not as a substitute for clinical relationships, behavioral health support, or individualized care planning. The infrastructure around monitoring matters as much as the monitoring itself: who receives the data, how quickly they act on it, and what the response protocol looks like when a result raises concern.
This is where the field still has meaningful work to do. The National Institute on Alcohol Abuse and Alcoholism's 2024–2028 strategic plan explicitly calls for data science approaches to individualize AUD treatment and guide recovery, signaling that federal research priorities are now aligned with the direction practitioners on the ground have been pointing toward for years. Integrating real-time monitoring data with behavioral health services, coordinating across the patient's support network, and developing response plans that are genuinely responsive rather than procedural all require deliberate design. Dr. Bohn points toward where this is heading:
"Going forward, I believe we will need to integrate monitoring technologies with behavioral health services, data analysis and customized interventions to develop true responsive systems. The future is not simply about tracking whether someone has achieved sobriety; the future will be about identifying risks and preventing relapse from occurring."
That vision, proactive rather than reactive, predictive rather than retrospective, describes a system built around the actual nature of addiction as a chronic condition. It is also, notably, the direction that chronic disease management in other areas of medicine has already moved. Emerging research funded by the National Institute on Alcohol Abuse and Alcoholism is now developing machine learning models that synthesize multiple data sources to predict lapse risk in real time, pointing toward a near future where monitoring systems don't just record what happened but anticipate what's coming. Addiction care is navigating the same transition, with similar stakes.
For practitioners evaluating their own monitoring strategies, the most useful question is whether the current approach would be considered adequate if applied to any other chronic condition. If the answer is no, if the follow-up is infrequent, the data is self-reported, and there is no structured early-intervention protocol, then the gap between stated clinical model and actual practice is worth closing.
The chronic disease framework for addiction is no longer a theoretical orientation. The AMA's 2025 report on substance use calls explicitly for removing treatment barriers and sustaining the progress that's been made, framing continued investment in monitoring and ongoing care as essential rather than optional. The monitoring infrastructure supporting patients in recovery should reflect that standard, built for the long arc of recovery rather than the moment of discharge, and capable of catching risk early enough to actually make a difference.
